Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices.

Eli Lilly Announces Refunds for 340B Overcharges

Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.